Authors:
DONALDSON DD
WHITTERS MJ
FITZ LJ
NEBEN TY
FINNERTY H
HENDERSON SL
OHARA RM
BEIER DR
TURNER KJ
WOOD CR
COLLINS M
Citation: Dd. Donaldson et al., THE MURINE IL-13 RECEPTOR ALPHA-2 - MOLECULAR-CLONING, CHARACTERIZATION, AND COMPARISON WITH MARINE IL-13 RECEPTOR, The Journal of immunology (1950), 161(5), 1998, pp. 2317-2324
Authors:
FITZ LJ
MORRIS JC
TOWLER P
LONG A
BURGESS P
GRECO R
WANG J
GASSAWAY R
NICKBARG E
KOVACIC S
CIARLETTA A
GIANNOTTI J
FINNERTY H
ZOLLNER R
BEIER DR
LEAK LV
TURNER KJ
WOOD CR
Citation: Lj. Fitz et al., CHARACTERIZATION OF MURINE FLT4 LIGAND VEGF-C, Oncogene, 15(5), 1997, pp. 613-618
Citation: Pr. Langersafer et al., STRATEGIES FOR THE APPLICATION OF FUNCTIONAL GENOMICS TECHNOLOGY TO BIOPHARMACEUTICAL DRUG DISCOVERY, Drug development research, 41(3-4), 1997, pp. 173-179
Authors:
COLLINS M
WHITTERS MJ
FITZ LJ
NEBEN TY
BEIER DR
FINNERTY H
HENDERSON SL
OHARA RM
TURNER KJ
WOOD CR
DONALDSON DD
Citation: M. Collins et al., COMPARISON OF 2 DISTINCT LIGAND-BINDING CHAINS FOR THE IL13 RECEPTOR IN THE MOUSE, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1169-1169
Authors:
FITZ LJ
MORRIS JC
TOWLER P
LONG AJ
BURGESS P
KOVACIC S
GIANNOTTI J
WANG J
GASSAWAY R
NICKBARG E
FINNERTY H
ZOLLNER R
HENNESSEY D
NEBEN S
TURNER K
WOOD CR
Citation: Lj. Fitz et al., PURIFICATION AND CLONING OF THE MURINE FLT4 LIGAND, Experimental hematology, 24(9), 1996, pp. 414-414